Increased expression of renal neutral endopeptidase in severe heart failure

Schulz, 1991, Characterisation of neutral endopeptidase 3.4.24.11 (NEP) in the kidney: comparison between normotensive, genetically hypertensive rats, J Enzyme Inhib, 4, 347, 10.3109/14756369109030399 Abassi, 1992, Role of neutral endopeptidase in the metabolism of endothelin, Hypertension, 20, 89, 10.1161/01.HYP.20.1.89 Ura, 1987, Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo, Kidney Int, 32, 507, 10.1038/ki.1987.239 Lu, 1997, The control of microvascular permeability and blood pressure by neutral endopeptidase, Nat Med, 3, 904, 10.1038/nm0897-904 Sonnenberg, 1988, Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney, Peptides, 9, 173, 10.1016/0196-9781(88)90024-1 Winaver, 1988, Hormonal determinants of sodium excretion in rats with experimental high-output heart failure, Am J Physiol, 254, R776 Cody, 1986, Atrial natriuretic factor in normal subjects and heart failure patients, J Clin Invest, 78, 1362, 10.1172/JCI112723 Redfield, 1989, Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure, Am J Physiol, 257, R917 Riegger, 1987, Atrial natriuretic factor in acute and chronic cardiac failure, J Cardiovasc Pharmacol, 10, S161, 10.1097/00005344-198706106-00022 Margulies, 1991, ANF-mediated renal cGMP generation in congestive heart failure, Am J Physiol., 260, F562 Cavero, 1990, Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure, Circulation, 82, 196, 10.1161/01.CIR.82.1.196 Burnett, 1986, Atrial natriuretic peptide elevation in congestive heart failure in the human, Science, 231, 1145, 10.1126/science.2935937 Raine, 1986, Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure, N Engl J Med, 315, 533, 10.1056/NEJM198608283150901 Abassi, 1991, Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure, Am J Physiol, 261, R858 Yechieli, 1993, Regulation of renal glomerular and papillary ANP receptors in rats with experimental heart failure, Am J Physiol, 265, F119 Tsunoda, 1988, Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure, Circ Res, 62, 155, 10.1161/01.RES.62.1.155 Kukkonen, 1992, Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: Effects of SCH 39.370, an endopeptidase inhibitor, and C- ANF-(4–23), a clearance receptor ligand, Endocrinology, 130, 755, 10.1210/en.130.2.755 Charles, 1996, Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep, Am J Physiol, 271, R373 Rademaker, 1997, Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure, Am J Physiol, 273, H2372 Perrella, 1991, Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs, J Clin Invest, 87, 1649, 10.1172/JCI115180 Wilkins, 1990, Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure, Proc Natl Acad Sci USA, 87, 6465, 10.1073/pnas.87.16.6465 Northridge, 1989, Effects of UK 69 578: A novel atriopeptidase inhibitor, Lancet, 591, 10.1016/S0140-6736(89)90714-9 Trippodo, 1991, Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats, J Cardiovasc Pharmacol, 18, 308, 10.1097/00005344-199109000-00002 Margulies, 1995, The role of neutral endopeptidase in dogs with evolving congestive heart failure, Circulation, 91, 2036, 10.1161/01.CIR.91.7.2036 Garcia, 1990, Simple, rapid, and effective method of producing aortocaval shunts in the rat, Cardiovasc Res, 24, 430, 10.1093/cvr/24.5.430 Willenbrock, 1996, Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt, Hypertension, 27, 1259, 10.1161/01.HYP.27.6.1259 Gutkowska, 1986, Atrial natriuretic factor in human plasma, Biochem Biophys Res Commun, 139, 287, 10.1016/S0006-291X(86)80111-5 Florentin, 1983, A highly sensitive fluorometric assay for “enkephalinase”, a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins, Methods Enzymol., 62 Heder, 1988, Zur Bestimmung von neutraler Metalloendopeptidase (Enkephalinase A) in biologischem Material, Pharmazie, 43, 637 Abassi, 1995, Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure, Hypertension, 25, 1178, 10.1161/01.HYP.25.6.1178 Wegner, 1996, Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure, Cardiovasc.Res., 31, 891, 10.1016/S0008-6363(96)00062-4 Margulies, 1990, Neutral endopeptidase inhibition potentiates the renal action of atrial natriuretic factor, Kidney Int, 38, 67, 10.1038/ki.1990.168 Trapani, 1989, Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide, J Cardiovasc Pharmacol, 14, 419, 10.1097/00005344-198909000-00010 Chen, 1999, Renal response to acute neural endopeptidase inhibition in mild and severe experimental heart failure, Circulation, 100, 2443, 10.1161/01.CIR.100.24.2443 Fielitz, 2002, Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure, Circulation, 105, 286, 10.1161/hc0302.103593 Matsumura, 1996, Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity, J Clin Invest, 97, 2192, 10.1172/JCI118660 Edwards, 1999, Distribution od neutral endopeptidase activity along the rat and rabbit nephron, Pharmacology, 59, 45, 10.1159/000028304 Knecht, 1999, Increased renal activity of neutral endopeptidase correlates with plasma ANP in different models of experimental left ventricular dysfunction, Circulation, 100, I-533 Roques, 1993, Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology, Pharmacol Rev, 45, 87 Huang, 1994, Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure, Circ Res, 75, 454, 10.1161/01.RES.75.3.454 Matsukawa, 1999, The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system, Proc Natl Acad Sci USA, 96, 7403, 10.1073/pnas.96.13.7403 Nagase, 1997, Role of natriuretic peptide receptor type C in dahl salt-sensitive hypertensive rats, Hypertension, 30, 177, 10.1161/01.HYP.30.2.177 Chiu, 1991, Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats, Am J Physiol, 260, R208 Andreassi, 2001, Up - regulation of ‘clearance’ receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones, Eur J Heart Fail, 3, 407, 10.1016/S1388-9842(01)00161-1